Infantile Spasms (West Syndrome): Prognosis, Treatment Response, and Outcomes

Prognostic Factors

  • Age at onset: <4 months → better; >6 months → worse.
  • Etiology:
    • Symptomatic (structural/metabolic/genetic): Prognosis follows underlying cause.
    • Cryptogenic (no cause found, normal development before onset): Better.
    • Tuberous Sclerosis Complex (TSC): Vigabatrin highly effective; early treatment improves neurodevelopment.
  • Hypsarrhythmia on EEG: Persistent hypsarrhythmia after treatment → worse cognitive outcome.
  • Treatment response: Cessation of spasms + resolution of hypsarrhythmia = best predictor.
  • Developmental status at onset: Normal prior development → better.

Treatment

  • First-line: Hormonal therapy – ACTH (corticotropin) or high-dose oral corticosteroids (prednisolone/prednisone). Vigabatrin (especially TSC).
  • Second-line: Ketogenic diet, topiramate, zonisamide, valproate, levetiracetam.
  • Surgery: Focal resection if structural lesion.

Outcome Statistics

  • Spasm freedom: ~50–70% with first-line therapy.
  • Subsequent epilepsy: 50–90% develop other seizure types (often Lennox-Gastaut).
  • Neurodevelopmental impairment: ~70–90% have intellectual disability / autism / behavioral issues; severity correlates with etiology and treatment delay.
  • Normal outcome: ~10–20% (mostly cryptogenic, early treated).

Critical Importance of Early Treatment

Each week of untreated spasms correlates with worse cognitive outcome. "Time is brain." Urgent referral to pediatric neurologist; EEG within days.

Multidisciplinary Care

  • Pediatric neurologist/epileptologist.
  • Developmental pediatrics, PT/OT/SLP.
  • Genetics (panel, microarray, TSC testing).
  • Family support, early intervention services.

Baby Health - Related Articles